Danhua Chemical Technology Co.,Ltd (SHA:600844)
China · Delayed Price · Currency is CNY 3.030
+0.010 (0.33%)
Jul 27, 2026, 2:45 PM CST
SHA:600844 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 819.12 | 814.67 | 762.82 | 855.91 | 926.52 | 1,087 |
Other Revenue | 12.01 | 11.43 | 7.1 | 5.16 | 7.3 | - |
| 831.13 | 826.1 | 769.92 | 861.08 | 933.82 | 1,087 | |
Revenue Growth (YoY) | -1.50% | 7.30% | -10.59% | -7.79% | -14.13% | 1.12% |
Cost of Revenue | 766.22 | 869.9 | 954.73 | 1,091 | 920.7 | 967.91 |
Gross Profit | 64.91 | -43.81 | -184.81 | -230.27 | 13.12 | 119.58 |
Selling, General & Admin | 84.51 | 91.77 | 108.92 | 109.16 | 121.07 | 134.12 |
Research & Development | - | 0.24 | 2.16 | 32.47 | 47.32 | 47.27 |
Other Operating Expenses | 18.85 | 17.08 | 16.61 | 17.79 | 21.02 | 24.66 |
Operating Expenses | 97.53 | 106.01 | 134.08 | 169.63 | 194.49 | 238.19 |
Operating Income | -32.62 | -149.81 | -318.9 | -399.91 | -181.37 | -118.61 |
Interest Expense | -23.94 | -21.77 | -22.68 | -10.79 | -13.06 | -16.24 |
Interest & Investment Income | 0.84 | 0.14 | 3.25 | 0.1 | 0.3 | 0.5 |
Currency Exchange Gain (Loss) | 0 | 0.01 | 0 | 0.01 | -0.01 | -0 |
Other Non Operating Income (Expenses) | 2.86 | -1.24 | -0.52 | 0.2 | 0.21 | -0.48 |
EBT Excluding Unusual Items | -52.86 | -172.68 | -338.85 | -410.39 | -193.93 | -134.85 |
Gain (Loss) on Sale of Investments | -2.35 | -2.31 | - | -19.01 | -8.39 | -15.79 |
Gain (Loss) on Sale of Assets | -0.17 | -0.57 | -11.02 | 0.22 | 0.61 | 3.46 |
Asset Writedown | -37.45 | -37.45 | - | -71.04 | -27.96 | - |
Other Unusual Items | 2.45 | 0.69 | -10.69 | 5.31 | 5.16 | -2.24 |
Pretax Income | -90.39 | -212.33 | -360.56 | -494.91 | -224.51 | -149.42 |
Income Tax Expense | -0.05 | 0.1 | 33.04 | 8.51 | 153.46 | -23.16 |
Earnings From Continuing Operations | -90.34 | -212.43 | -393.6 | -503.42 | -377.97 | -126.26 |
Minority Interest in Earnings | 14.16 | 43.03 | 86.09 | 110.47 | 84.99 | 22.19 |
Net Income | -76.18 | -169.4 | -307.51 | -392.95 | -292.98 | -104.07 |
Net Income to Common | -76.18 | -169.4 | -307.51 | -392.95 | -292.98 | -104.07 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,016 | 1,017 | 1,017 | 1,016 | 1,017 | 1,016 |
Shares Outstanding (Diluted) | 1,016 | 1,017 | 1,017 | 1,016 | 1,017 | 1,016 |
Shares Change (YoY) | -0.05% | 0.02% | 0.01% | -0.02% | 0.03% | -0.02% |
EPS (Basic) | -0.07 | -0.17 | -0.30 | -0.39 | -0.29 | -0.10 |
EPS (Diluted) | -0.07 | -0.17 | -0.30 | -0.39 | -0.29 | -0.10 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -90.15 | -114.66 | -79.74 | -106.73 | -51.56 | 120.74 |
Free Cash Flow Per Share | -0.09 | -0.11 | -0.08 | -0.10 | -0.05 | 0.12 |
Gross Margin | 7.81% | -5.30% | -24.00% | -26.74% | 1.41% | 11.00% |
Operating Margin | -3.92% | -18.14% | -41.42% | -46.44% | -19.42% | -10.91% |
Profit Margin | -9.17% | -20.51% | -39.94% | -45.63% | -31.37% | -9.57% |
Free Cash Flow Margin | -10.85% | -13.88% | -10.36% | -12.39% | -5.52% | 11.10% |
EBITDA | 51.37 | -20.46 | -139.25 | -213.04 | 8.69 | 91.53 |
EBITDA Margin | 6.18% | -2.48% | -18.09% | -24.74% | 0.93% | 8.42% |
D&A For EBITDA | 83.99 | 129.35 | 179.64 | 186.87 | 190.06 | 210.15 |
EBIT | -32.62 | -149.81 | -318.9 | -399.91 | -181.37 | -118.61 |
EBIT Margin | -3.92% | -18.14% | -41.42% | -46.44% | -19.42% | -10.91% |
Revenue as Reported | 831.13 | 826.1 | 769.92 | 861.08 | 933.82 | 1,087 |